Maxim Levin
Impact in
- Physiology top 10%
- Magnetic and Electromagnetic Effects
-
- Protease and Inhibitor Mechanisms
Papers in
-
- Glycosylation and Glycoproteins Research 1
- Geomagnetism and Paleomagnetism Studies 1
- Oncology 3
- Peptidase Inhibition and Analysis 2
- Co-authors
- Irit Sagi (4 shared papers)Inna Solomonov (2 shared papers)Yael Udi (1 shared paper)Yoav Peleg (2 shared papers)Kfir Ben‐Harush (1 shared paper)Ashraf Brik (1 shared paper)Tal Moyal (1 shared paper)Geula Davidov (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (1 paper)Cancers (1 paper)Bioorganic & Medicinal Chemistry (1 paper)Scientific Reports (1 paper)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Maxim Levin
6 papers receiving 349 citations
Peers
Comparison fields: 5 of 83
- Physiology 42
- Cancer Research 103
- Immunology and Allergy 29
- Oncology 114
- Molecular Biology 170
Countries citing papers authored by Maxim Levin
This map shows the geographic impact of Maxim Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxim Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxim Levin more than expected).
Fields of papers citing papers by Maxim Levin
This network shows the impact of papers produced by Maxim Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxim Levin. The network helps show where Maxim Levin may publish in the future.
Co-authors
The 25 scholars most cited alongside Maxim Levin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 155 | |
| 2 | 2011 | 93 | |
| 3 | 2016 | 72 | |
| 4 | 2021 | 23 | |
| 5 | 2021 | 9 | |
| 6 | 2013 | 5 | |
| 7 | 2023 | 0 |
About Maxim Levin
Maxim Levin is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Biotechnology and Cancer Research, having authored 7 papers that have together received 357 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (2 papers), Protease and Inhibitor Mechanisms (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Advanced Scientific Research Methods (1 paper), Glycosylation and Glycoproteins Research (1 paper), Microbial Metabolites in Food Biotechnology (1 paper), Geomagnetism and Paleomagnetism Studies (1 paper) and Advanced Computational Techniques in Science and Engineering (1 paper). The work is most often cited by research in Physiology (42 citations), Cancer Research (103 citations), Immunology and Allergy (29 citations), Oncology (114 citations) and Molecular Biology (170 citations). Maxim Levin has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Irit Sagi, Inna Solomonov, Yael Udi, Yoav Peleg, Kfir Ben‐Harush, Ashraf Brik, Tal Moyal, Geula Davidov, Arash Komeili and Raz Zarivach. Their work appears in journals such as Proceedings of the National Academy of Sciences, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, Cancers, Bioorganic & Medicinal Chemistry and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.